We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Doubt of the benefit

13 December 2016 By Jeffrey Goldfarb

The U.S. medical insurer’s CEO now says cost cuts following its Humana acquisition are forecast at $3 bln a year, not the original $1.25 bln. Extra efficiencies conveniently help Aetna with its antitrust defense. The big revision should feed skepticism about all such estimates.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)